Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Cook

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Critical Care Medicine|June 10, 2003
The Toll of sepsis: altered innate immunity in polymicrobial sepsisJames A Cook
Critical Care Medicine|December 13, 2005
EicosanoidsJames A Cook
Journal of Endotoxin Research|May 4, 2004
Molecular mechanisms of endotoxin toleranceHongkuan Fan, James A Cook
Shock (Augusta, Ga.)|April 19, 2005
Peroxisome proliferator-activated receptor-gamma is a new therapeutic target in sepsis and inflammationBasilia Zingarelli, James A Cook
Shock (Augusta, Ga.)|June 19, 2002
Inducible nitric oxide synthase is not required in the development of endotoxin tolerance in miceBasilia Zingarelli, Paul W Hake, James A Cook
Shock (Augusta, Ga.)|July 11, 2007
Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cellsJennifer Kaplan, James A Cook, Michael O'Connor, et al.
Immunology|November 22, 2007
Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophagesBasilia Zingarelli, Hongkuan Fan, Sarah Ashton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathwaysBasilia Zingarelli, Maeve Sheehan, Paul W Hake, et al.
Shock (Augusta, Ga.)|June 18, 2004
Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activationHongkuan Fan, Octavia M Peck, George E Tempel, et al.
Critical Care (London, England)|December 20, 2015
Plasma levels of microRNA are altered with the development of shock in human sepsis: an observational studyAndrew J Goodwin, Changrun Guo, James A Cook, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Critical Care Medicine|June 10, 2003
The Toll of sepsis: altered innate immunity in polymicrobial sepsisJames A Cook
Critical Care Medicine|December 13, 2005
EicosanoidsJames A Cook
Journal of Endotoxin Research|May 4, 2004
Molecular mechanisms of endotoxin toleranceHongkuan Fan, James A Cook
Shock (Augusta, Ga.)|April 19, 2005
Peroxisome proliferator-activated receptor-gamma is a new therapeutic target in sepsis and inflammationBasilia Zingarelli, James A Cook
Shock (Augusta, Ga.)|June 19, 2002
Inducible nitric oxide synthase is not required in the development of endotoxin tolerance in miceBasilia Zingarelli, Paul W Hake, James A Cook
Shock (Augusta, Ga.)|July 11, 2007
Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cellsJennifer Kaplan, James A Cook, Michael O'Connor, et al.
Immunology|November 22, 2007
Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophagesBasilia Zingarelli, Hongkuan Fan, Sarah Ashton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathwaysBasilia Zingarelli, Maeve Sheehan, Paul W Hake, et al.
Shock (Augusta, Ga.)|June 18, 2004
Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activationHongkuan Fan, Octavia M Peck, George E Tempel, et al.
Critical Care (London, England)|December 20, 2015
Plasma levels of microRNA are altered with the development of shock in human sepsis: an observational studyAndrew J Goodwin, Changrun Guo, James A Cook, et al.
Pageof 5